Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor

J. Fan, D. Char, G. J. Bagby, M. C. Gelato, C. H. Lang

Research output: Contribution to journalArticle

178 Citations (Scopus)

Abstract

The purpose of the present study was to determine 1) whether exogenous administration of tumor necrosis factor-α (TNF-α) alters insulin-like growth factor-I (IGF-I) and IGF-binding proteins (BPs) and 2) whether the enhanced endogenous production of TNF mediates the lipopolysaccharide (LPS)- induced changes in the IGF system. The overnight infusion of murine TNF-α reduced circulating concentrations of both growth hormone (GH) and IGF-I in fasted rats. Furthermore, TNF-α decreased IGF-I content in liver, gastrocnemius muscle, and pituitary. In contrast, TNF-α increased IGF-I content in kidney and brain. IGFBP-1 was increased in plasma, liver, and muscle in response to TNF-α. In a second study, rats were injected with LPS after treatment with a neutralizing anti-TNF antibody (Ab), and blood and tissues were collected 4 h later. In LPS-treated rats, plasma concentrations of GH and IGF-I were reduced. LPS also decreased the IGF-I content in liver and skeletal muscle and increased plasma, liver, and muscle concentrations of IGFBP-1. Pretreatment with anti-TNF Ab attenuated the LPS-induced reduction in IGF-I and the increased IGFBP-1 in plasma and liver and completely prevented the decrease in IGF-I observed in muscle. In contrast, the LPS- induced decrease in plasma GH and the increased IGFBP-1 observed in muscle were unaltered by the anti-TNF Ab. These results indicate that the GH/IGF axis is sensitive to TNF-α and that enhanced endogenous production of TNF mediates a major portion of the LPS-induced decrease in IGF-I in plasma, liver, and muscle, as well as a smaller portion of the concomitant elevation in IGFBP-1 in plasma and liver.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Volume269
Issue number5 38-5
StatePublished - Jan 1 1995

Fingerprint

Insulin-Like Growth Factor Binding Proteins
Insulin-Like Growth Factor I
Tumor Necrosis Factor-alpha
Insulin-Like Growth Factor Binding Protein 1
Lipopolysaccharides
Liver
Growth Hormone
Muscles
Anti-Idiotypic Antibodies
Skeletal Muscle
Insulin-Like Growth Factor Binding Protein 2
Neutralizing Antibodies
Kidney

All Science Journal Classification (ASJC) codes

  • Physiology
  • Physiology (medical)

Cite this

@article{ede7a248564342dd902f39561ec2f65c,
title = "Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor",
abstract = "The purpose of the present study was to determine 1) whether exogenous administration of tumor necrosis factor-α (TNF-α) alters insulin-like growth factor-I (IGF-I) and IGF-binding proteins (BPs) and 2) whether the enhanced endogenous production of TNF mediates the lipopolysaccharide (LPS)- induced changes in the IGF system. The overnight infusion of murine TNF-α reduced circulating concentrations of both growth hormone (GH) and IGF-I in fasted rats. Furthermore, TNF-α decreased IGF-I content in liver, gastrocnemius muscle, and pituitary. In contrast, TNF-α increased IGF-I content in kidney and brain. IGFBP-1 was increased in plasma, liver, and muscle in response to TNF-α. In a second study, rats were injected with LPS after treatment with a neutralizing anti-TNF antibody (Ab), and blood and tissues were collected 4 h later. In LPS-treated rats, plasma concentrations of GH and IGF-I were reduced. LPS also decreased the IGF-I content in liver and skeletal muscle and increased plasma, liver, and muscle concentrations of IGFBP-1. Pretreatment with anti-TNF Ab attenuated the LPS-induced reduction in IGF-I and the increased IGFBP-1 in plasma and liver and completely prevented the decrease in IGF-I observed in muscle. In contrast, the LPS- induced decrease in plasma GH and the increased IGFBP-1 observed in muscle were unaltered by the anti-TNF Ab. These results indicate that the GH/IGF axis is sensitive to TNF-α and that enhanced endogenous production of TNF mediates a major portion of the LPS-induced decrease in IGF-I in plasma, liver, and muscle, as well as a smaller portion of the concomitant elevation in IGFBP-1 in plasma and liver.",
author = "J. Fan and D. Char and Bagby, {G. J.} and Gelato, {M. C.} and Lang, {C. H.}",
year = "1995",
month = "1",
day = "1",
language = "English (US)",
volume = "269",
journal = "American Journal of Physiology",
issn = "0363-6119",
publisher = "American Physiological Society",
number = "5 38-5",

}

Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor. / Fan, J.; Char, D.; Bagby, G. J.; Gelato, M. C.; Lang, C. H.

In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 269, No. 5 38-5, 01.01.1995.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor

AU - Fan, J.

AU - Char, D.

AU - Bagby, G. J.

AU - Gelato, M. C.

AU - Lang, C. H.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - The purpose of the present study was to determine 1) whether exogenous administration of tumor necrosis factor-α (TNF-α) alters insulin-like growth factor-I (IGF-I) and IGF-binding proteins (BPs) and 2) whether the enhanced endogenous production of TNF mediates the lipopolysaccharide (LPS)- induced changes in the IGF system. The overnight infusion of murine TNF-α reduced circulating concentrations of both growth hormone (GH) and IGF-I in fasted rats. Furthermore, TNF-α decreased IGF-I content in liver, gastrocnemius muscle, and pituitary. In contrast, TNF-α increased IGF-I content in kidney and brain. IGFBP-1 was increased in plasma, liver, and muscle in response to TNF-α. In a second study, rats were injected with LPS after treatment with a neutralizing anti-TNF antibody (Ab), and blood and tissues were collected 4 h later. In LPS-treated rats, plasma concentrations of GH and IGF-I were reduced. LPS also decreased the IGF-I content in liver and skeletal muscle and increased plasma, liver, and muscle concentrations of IGFBP-1. Pretreatment with anti-TNF Ab attenuated the LPS-induced reduction in IGF-I and the increased IGFBP-1 in plasma and liver and completely prevented the decrease in IGF-I observed in muscle. In contrast, the LPS- induced decrease in plasma GH and the increased IGFBP-1 observed in muscle were unaltered by the anti-TNF Ab. These results indicate that the GH/IGF axis is sensitive to TNF-α and that enhanced endogenous production of TNF mediates a major portion of the LPS-induced decrease in IGF-I in plasma, liver, and muscle, as well as a smaller portion of the concomitant elevation in IGFBP-1 in plasma and liver.

AB - The purpose of the present study was to determine 1) whether exogenous administration of tumor necrosis factor-α (TNF-α) alters insulin-like growth factor-I (IGF-I) and IGF-binding proteins (BPs) and 2) whether the enhanced endogenous production of TNF mediates the lipopolysaccharide (LPS)- induced changes in the IGF system. The overnight infusion of murine TNF-α reduced circulating concentrations of both growth hormone (GH) and IGF-I in fasted rats. Furthermore, TNF-α decreased IGF-I content in liver, gastrocnemius muscle, and pituitary. In contrast, TNF-α increased IGF-I content in kidney and brain. IGFBP-1 was increased in plasma, liver, and muscle in response to TNF-α. In a second study, rats were injected with LPS after treatment with a neutralizing anti-TNF antibody (Ab), and blood and tissues were collected 4 h later. In LPS-treated rats, plasma concentrations of GH and IGF-I were reduced. LPS also decreased the IGF-I content in liver and skeletal muscle and increased plasma, liver, and muscle concentrations of IGFBP-1. Pretreatment with anti-TNF Ab attenuated the LPS-induced reduction in IGF-I and the increased IGFBP-1 in plasma and liver and completely prevented the decrease in IGF-I observed in muscle. In contrast, the LPS- induced decrease in plasma GH and the increased IGFBP-1 observed in muscle were unaltered by the anti-TNF Ab. These results indicate that the GH/IGF axis is sensitive to TNF-α and that enhanced endogenous production of TNF mediates a major portion of the LPS-induced decrease in IGF-I in plasma, liver, and muscle, as well as a smaller portion of the concomitant elevation in IGFBP-1 in plasma and liver.

UR - http://www.scopus.com/inward/record.url?scp=0028789723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028789723&partnerID=8YFLogxK

M3 - Article

C2 - 7503312

AN - SCOPUS:0028789723

VL - 269

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6119

IS - 5 38-5

ER -